Credit rating Suisse shares are a ‘steal,’ say new Saudi backers right after having 9.9% stake

Credit rating Suisse shares are a ‘steal,’ say new Saudi backers right after having 9.9% stake


Essential Points
  • Saudi Nationwide Lender, the kingdom’s most significant financial institution and greater part-owned by the Saudi govt, introduced Wednesday that it was investing up to $1.5 billion in Credit history Suisse — symbolizing a stake of up to 9.9%.
  • The Swiss loan company posted a third-quarter net loss of 4.034 billion Swiss francs ($4.09 billion) past week,  significantly worse than analyst estimates, and introduced a significant strategic overhaul.
  • Shares are down close to 55% this yr following numerous scandals, management adjustments and weak earnings releases.



Resource

These underperforming groups may deliver AI-electric appeal. Here’s why.
Finance

These underperforming groups may deliver AI-electric appeal. Here’s why.

ETF Edge These underperforming groups may deliver AI-electric appeal. Here’s why. Published Sat, Nov 15 202511:00 AM EST Blair Bao WATCH LIVE Source

Read More
Warren Buffett’s Berkshire Hathaway reveals new position in Alphabet
Finance

Warren Buffett’s Berkshire Hathaway reveals new position in Alphabet

Warren Buffett speaks during the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska on May 3, 2025. CNBC Warren Buffett’s Berkshire Hathaway revealed a new position in Alphabet, making the Google parent the conglomerate’s 10th largest equity holding at the end of September, according to a regulatory filing. Berkshire disclosed a $4.3 billion stake in […]

Read More
Stocks making the biggest moves midday: Whirlpool, Topgolf Callaway, Nvidia, Stubhub & more
Finance

Stocks making the biggest moves midday: Whirlpool, Topgolf Callaway, Nvidia, Stubhub & more

Check out the companies making the biggest moves midday: Scholar Rock — The Cambridge, Massachusetts-based biotech jumped 23% after saying it ” completed constructive and collaborative in-person Type A meeting ” with the FDA on Wednesday for a biologics license application for apitegromab, a spinal muscular atrophy treatment. Officials from Novo Nordisk’s Catalent Indiana joined […]

Read More